Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
66,575,924
-
Share change
-
-4,274,019
-
Total reported value
-
$222,407,153
-
Put/Call ratio
-
131%
-
Price per share
-
$3.34
-
Number of holders
-
130
-
Value change
-
-$12,653,106
-
Number of buys
-
54
-
Number of sells
-
71
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2020
As of 31 Dec 2020,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,575,924 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, PRUDENTIAL FINANCIAL INC, ROYCE & ASSOCIATES LP, HealthInvest Partners AB, GEODE CAPITAL MANAGEMENT, LLC, and LSV ASSET MANAGEMENT.
This page lists
130
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.